131 results
Page 5 of 7
424B3
fvnyfvn fbf
7 Jun 21
Prospectus supplement
9:16am
424B3
9kbuoy597t74oz
7 Jun 21
Prospectus supplement
9:16am
6-K
EX-99.1
u3l08mach5xjp8tu
7 Jun 21
FDA confirms NDA for Oleogel-S10 will not require an Advisory Committee Meeting
9:13am
424B3
0rpug7 kfaka8s
3 Jun 21
Prospectus supplement
6:06am
424B3
21v13bkonj5h
3 Jun 21
Prospectus supplement
6:06am
6-K
EX-99.1
y16dt o7t
3 Jun 21
FDA Grants Priority Review for New Drug Application for Oleogel-S10 for the Treatment of Epidermolysis Bullosa
6:03am
424B3
94d7 n41kjz9jevsv8c
2 Jun 21
Prospectus supplement
10:10am
424B3
4cwrycjfnd 7nv0
2 Jun 21
Prospectus supplement
10:09am
424B3
3mv4he6ps3ah60jifesm
2 Jun 21
Prospectus supplement
10:08am
6-K
EX-99.1
tojqe8rbpyhk
2 Jun 21
Amryt Announces FDA Acceptance of New Drug Application for Oleogel-S10 for the Treatment of Epidermolysis Bullosa
9:02am
425
ei8hhj6nqnta9
5 May 21
Business combination disclosure
5:26pm
425
h2q7hjpsp7g7 ak9
5 May 21
Business combination disclosure
5:24pm
6-K
EX-99.5
dn5lz9p6yb6hsyjs5k
5 May 21
Agreement and Plan of Merger
5:19pm
6-K
EX-99.1
q8qi0f jf1i7n4gh97w
5 May 21
Amryt Reports Record Q1 2021 Financial and Operating Results
9:40am
6-K
EX-99.1
8qet0s
5 May 21
Amryt Pharma to Acquire Chiasma, Inc. to Further Strengthen Global Leadership in Rare and Orphan Diseases
8:45am
20-F
iogzjoy2fxz5yldro
30 Apr 21
Annual report (foreign)
12:53pm
6-K
EX-99.6
nii5r kx72ykyw4mb
31 Mar 21
Amryt and Medison Pharma Sign Distribution Agreement for Myalepta® (metreleptin) in Canada
7:00am
6-K
EX-99.4
m4f1de djhvx9
31 Mar 21
Amryt and Medison Pharma Sign Distribution Agreement for Myalepta® (metreleptin) in Canada
7:00am
6-K
EX-99.3
x23j3klscx8fwk
31 Mar 21
Amryt and Medison Pharma Sign Distribution Agreement for Myalepta® (metreleptin) in Canada
7:00am
6-K
EX-99.1
2w5esdks
31 Mar 21
Amryt and Medison Pharma Sign Distribution Agreement for Myalepta® (metreleptin) in Canada
7:00am